NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

flipper, I don’t think they needed to have 50 per month capacity, but that is simply the capacity of the initial phase 1A buildout.

The initial phase IA buildout of two suites with multiple isolated high-grade (B) cleanrooms, could first be utilized for Northwest Bio’s compassionate use manufacturing, and then later when Advent completes the build out of Phase 1B as Northwest Bio transitions to the closed, automated commercial manufacturing process in a large, lower-grade (C) suite, Advent can use the higher grade, isolated, clean rooms for their other clients. Sawston is eventually intended as a multi-product facility, and I think with the limited cell therapy manufacturing capacity available, those high-grade manufacturing suites will be utilized.

I’ve said before, that I don’t think the space that Advent subleases (capacity for 50 per month) is sufficient for commercial production, but it will be sufficient for small cell therapy companies that contract with Advent to manufacture for their investigational, clinical programs. Those smaller programs generally begin with manual manufacturing that require that type of suite with isolated, high-grade rooms.